Company / Financials
Amgen Financials
FY2009-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$36.8B
FY2025 · +10.0% YoY
Net Income
$7.7B
FY2025 · +88.5% YoY
Profit Margin
21.0%
FY2025 · net income / revenue
ROE
89.1%
FY2025 · return on equity
Total Assets
$90.6B
FY2025
Total Debt
$54.6B
6.31x debt/equity
Equity
$8.7B
FY2025
ROA
8.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$36.8B+10.0% YoYNet Income HistoryProfit after all expenses and taxes$7.7B+88.5% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold$12.0B-6.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes$9.1B+25.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$7.0B-0.6% YoYR&D Expense HistoryResearch and development spending$7.3B+21.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$2.8B-12.7% YoYIncome Tax HistoryTotal income tax expense$1.3B+143.7% YoYEPS (Basic) HistoryBasic earnings per share$12.56+3.1% YoY